Search details
1.
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
Cell
; 164(5): 1060-1072, 2016 Feb 25.
Article
in English
| MEDLINE | ID: mdl-26919435
2.
Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis.
Genes Dev
; 34(15-16): 1051-1064, 2020 08 01.
Article
in English
| MEDLINE | ID: mdl-32675324
3.
Germline Elongator mutations in Sonic Hedgehog medulloblastoma.
Nature
; 580(7803): 396-401, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32296180
4.
Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations.
Int J Cancer
; 154(8): 1455-1463, 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38175816
5.
Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas.
Acta Neuropathol
; 147(1): 24, 2024 Jan 24.
Article
in English
| MEDLINE | ID: mdl-38265522
6.
Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology.
Acta Neuropathol
; 147(1): 23, 2024 Jan 24.
Article
in English
| MEDLINE | ID: mdl-38265527
7.
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
J Neurooncol
; 168(2): 317-332, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38630384
8.
DNA methylation-based classification of central nervous system tumours.
Nature
; 555(7697): 469-474, 2018 03 22.
Article
in English
| MEDLINE | ID: mdl-29539639
9.
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
Nature
; 553(7686): 101-105, 2018 01 04.
Article
in English
| MEDLINE | ID: mdl-29258295
10.
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Acta Neuropathol
; 145(5): 667-680, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36933012
11.
Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR).
Pediatr Blood Cancer
; 70(7): e30363, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37066598
12.
[Pediatric Intracranial Ependymoma - Recommendations for First-Line Treatment from the German HIT-MED study group]. / Kinder und Jugendliche mit intrakraniellem Ependymom Empfehlungen der HIT-MED-Studiengruppe der GPOH zur Erstlinientherapie.
Klin Padiatr
; 235(3): 167-177, 2023 May.
Article
in German
| MEDLINE | ID: mdl-37172610
13.
Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
; 23(8): e393-e401, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35901835
14.
Important Requirements for the Selection of Internal Standards during the Development of Desorption/Ionization Assays for Drug Quantification in Biological Matrices-A Practical Example.
Molecules
; 27(3)2022 Jan 21.
Article
in English
| MEDLINE | ID: mdl-35163955
15.
Targeting fibroblast growth factor receptors to combat aggressive ependymoma.
Acta Neuropathol
; 142(2): 339-360, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34046693
16.
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Acta Neuropathol
; 142(5): 841-857, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34417833
17.
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies.
J Neurooncol
; 155(2): 193-202, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34657224
18.
Rapid MALDI-MS Assays for Drug Quantification in Biological Matrices: Lessons Learned, New Developments, and Future Perspectives.
Molecules
; 26(5)2021 Feb 26.
Article
in English
| MEDLINE | ID: mdl-33652935
19.
Molecular characterization of histopathological ependymoma variants.
Acta Neuropathol
; 139(2): 305-318, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31679042
20.
Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker.
Acta Neuropathol
; 139(3): 583-596, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31781912